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Statement of Purpose  
 
The purpose of this capstone project was to identify evidence-based practices relating to 
anxiety disorders and cannabis use throughout the lifespan.  Identification of the practices 
will more effectively meet the needs of the clients served at the Dual Recovery Program 
and allow the agency to best serve clients with co-occurring anxiety disorders and 
cannabis use in a parallel manner.  The literature indicates that there is a  correlation 
between anxiety disorders and cannabis abuse (Buckner & Schmidt, 2011; Buckner,  
Zvolensky, & Schmidt, 2012; Bricker, et al., 2006; Bonn-Miller, Vujanovic, Boden, & Gross, 
2011).  If the anxiety disorder can be properly diagnosed and treated early on with 
evidence-based treatment and recommended interventions, the likelihood for lifetime 
marijuana use will decrease (Substance Abuse & Mental Health Services Administration 
[SAMSHA], 2012). 
 
Methodology 
 
A systematic review was conducted to identify evidence-based treatment modalities for 
co-occurring anxiety disorders and marijuana use in an outpatient setting.  “A systematic 
review retrieves, appraises and summarizes all the available evidence on a specific 
(health) question and then attempts to reconcile and interpret it” (White & Schmidt, 
2005).   
Key research terms include: “dual diagnosis”, “co-occurring disorders”, “integrated dual 
disorders treatment”, “cannabis”, “marijuana”, “evidence-based practices in treating co-
occurring/dual disorders”, “treating co-occurring/dual disorders”, “marijuana and 
anxiety”, “marijuana use and general anxiety disorders”, “marijuana use and obsessive 
compulsive disorder”, “marijuana and post-traumatic stress disorder”, “marijuana and 
social anxiety”, “marijuana use and panic disorder”, “marijuana use in adolescents”, 
“marijuana use in adults”, “Marijuana use in rural areas”, “pharmacotherapy and 
anxiety”, “rural mental health barriers”, and “anxiety disorders”.  
The primary databases utilized for this review were: Academic Search Premier, ERIC, 
SAGE Premier, Social Services Abstracts, Psychology Abstracts, Science Direct, SAMHSA, 
NIMH, NAMI, NIDA, NIH, Drug and Alcohol Services Information System(DASIS) Reports, 
Treatment Episode Data Set (TED) Reports, Office of Applied Studies (OAS) Reports, 
National Survey on Drug Use and Health (NSDUH) Report, Drug Abuse Warning Network 
(DAWN) Reports, and other scholarly journals, such as, Mental Health and Substance 
Abuse, Journal of Dual Diagnosis, and Journal of Addictive Diseases. 
Implications for Practice 
 
• “Due to high prevalence of marijuana in anxiety disorders, it is important to screen for 
marijuana with persons with anxiety”(Bonn-Miller & Zvolensky, Leen-Feldner, Feldner, 
& Yartz, 2005). 
• “Programs that offer treatment to individuals with co-occurring disorders ensure 
clinical staff has advanced specialized training to increase the needed capacity to 
provide co-occurring disorders treatment within the program and create a “no wrong 
door” experience for patients” (SAMHSA, 2011).   
• “Concurrent and integrated treatments have become the norm and there has been a 
gradual dismantling of the silos”(Bernardy, Hamblen, Friedman, & Kivlahan, 2011).  It 
is important to treat both disorders concurrently in order to treat the whole person.  
Integrated care is more cost-effective than treating the disorders separately.   
• There was limited research on specific co-occurring anxiety disorders and marijuana 
use despite the high rates of each in the United States and the world.  Future research 
is necessary to be able to best serve individuals with these comorbidities. 
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Research Question 
 
What are the evidence-based practices for treating co-occurring anxiety disorders and 
cannabis use in adolescents, adults and older adults in an outpatient dual recovery 
treatment setting? 
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Key Findings  
 
• Marijuana continues to be the most frequently used and abused illicit substance in the 
world and anxiety disorders are the most prevalent of the psychiatric disorders (Hogan 
et al., 2010; Minnesota Department of Human Services [MDHS], 2012; United Nations 
Office on Drugs and Crime, 2012). 
• Findings indicate the importance of treating both disorders concurrently with an 
integrated approach (SAMHSA, 2012). 
• Early detection of anxiety disorders is important to alleviate possible substance use 
disorders and dependence later in life. 
• Psychotherapy and pharmacological interventions should be used in conjunction when 
indicated (SAMHSA, 2012). 
• Best-practices include: cognitive-behavioral therapy, exposure-therapy, family-
psychoeducation, case management, 12 step-program, self-help groups, psycho-
education, motivational interviewing, and behavioral therapies, including, deep 
breathing techniques, relaxation, and contingency management (Drake et al., 2001; 
Hall, Vaugha-Sarrazin, & Huber, 2008; Myrick & Wright, 2008; Brady & Verduin, 2005). 
• “Medications for addressing an individual’s mental disorder is likely to be the same 
medication for addressing these symptoms when the individual is diagnosed with a co-
occurring substance use disorder and vice versa” (SAMHSA, 2012). 
Figure 1: Mutual Maintenance Model 
Figure 2: Onset of Disorder 
Table 1: Annual Prevalence of 
Cannabis Use at the Global Level 
